Comparison of the metabolic profiles and their cardiovascular event risks of metformin users versus insulin users. A cohort study of people with type 2 diabetes from the UK Biobank
Metformin and insulin users have different metabolic profiles and a consistent pattern emerged that the metabolic profile of metformin users is favorable compared to the one of insulin users due to a lower associated MACE risk.
Authors
- Ben Schöttker (ORCID: https://orcid.org/0000-0002-1217-4521)
- Ruijie Xie (ORCID: https://orcid.org/0000-0002-1635-962X)
- Hermann Brenner (ORCID: https://orcid.org/0000-0002-6129-1572)
- Christian Herder (ORCID: https://orcid.org/0000-0002-2050-093X)
- Li-Ju Chen
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- Düsseldorf University Hospital (DE)
- Deutsches Diabetes-Zentrum e.V. (DE)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- Diabetes Research and Clinical Practice
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1016/j.diabres.2025.112108
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Wellcome Trust
- British Heart Foundation
- Northwest Regional Development Agency
- Medical Research Council